These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8712805)

  • 1. The current status of the implantable cardioverter defibrillator.
    Gillis AM
    Annu Rev Med; 1996; 47():85-93. PubMed ID: 8712805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The implantable cardioverter/defibrillator].
    Kuck KH; Siebels J; Schlüter M; Meinertz T
    Herz; 1994 Oct; 19(5):287-93. PubMed ID: 8001901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
    Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications and contraindications for therapy with implantable cardioverters/defibrillators].
    Neuzner J; Pitschner HF; Schlepper M
    Herz; 1994 Oct; 19(5):278-86. PubMed ID: 8001900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Implantable cardioverter-defibrillator(ICD)].
    Kurita T
    Nihon Rinsho; 2002 Jul; 60(7):1353-60. PubMed ID: 12136614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
    Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC
    Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications for an implantable cardioverter/defibrillator].
    Schwab JO; Lüderitz B
    Internist (Berl); 2007 Jul; 48(7):715-23; quiz 724-5. PubMed ID: 17541533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects of defibrillator therapy].
    Brachmann J; Hilbel T; Beyer T; Schöls W; Karolyi L; Freigang K; Becker R; Bauer A; Kübler W
    Z Kardiol; 1996; 85 Suppl 6():83-9. PubMed ID: 9064987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The implantable cardioverter/defibrillator (ICD). Developments up to the present time and future perspectives].
    Brachmann J; Hilbel T; Schöls W; Beyer T; Schweizer M; Sterns L; Karolyi L; Melichercik J; Freigang KD; Kübler W
    Herz; 1994 Oct; 19(5):246-50. PubMed ID: 8001897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined therapy with transvenous cardioverter/defibrillator and anti-bradycardia pacemaker systems].
    Sticherling C; Klingenheben T; Skupin M; Li YG; Hohnloser SH
    Z Kardiol; 1997 Feb; 86(2):105-12. PubMed ID: 9173694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
    Sanghera R; Sanders R; Husby M; Bentsen JG
    Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
    Borne RT; Varosy PD; Masoudi FA
    JAMA Intern Med; 2013 May; 173(10):859-65. PubMed ID: 23546173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The subcutaneous defibrillator: a review of the literature.
    Aziz S; Leon AR; El-Chami MF
    J Am Coll Cardiol; 2014 Apr; 63(15):1473-9. PubMed ID: 24530663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous implantable cardioverter-defibrillator technology.
    Gupta A; Al-Ahmad A; Wang PJ
    Heart Fail Clin; 2011 Apr; 7(2):287-94, x. PubMed ID: 21439506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.